Appendix 4D and Interim Financial Report
Released
Released
Announcement PDF
ASX Announcement
29 February 2024
ASX RELEASE ǀ CLEARVUE TECHNOLOGIES LIMITED
(ASX:CPV | OTC:CVUEF)
ClearVue on track to accelerate commercialisation following first
commercial orders
Appendix 4D & Half Year Activities Report
H1 FY24 Highlights
•
•
•
•
•
•
•
•
ClearVue clear solar glass certified fire safe and approved for buildings over 18 metres and in
high-risk environments such as hospitals, schools, and hotels
Secured first commercial order in Australia to supply Gen-2 ClearVuePV solar windows for the
CFMEU Training and Wellness Centre in Melbourne
Secured A$250k contract for ClearVuePV Solar Glazing for a greenhouse project in California
Confirmed independent, third-party verification by Singapore Building and Construction Authority
(BCA) of the real-world performance of ClearVue’s technology benefits for tropical climates
o 22.8% reduction in cooling load and 7.5% overall energy savings after accounting for energy
generation (Gen-2 IGUs only)
o 71% overall energy savings achieved when used with ClearVue’s Spandrel Solution
o Improved thermal comfort for building occupants and reduced imperceptible glare
Gen-2 IGUs produced on a mass-scale production run in an industry standard IGU production line
without changes to standardised lines, reducing costs and increasing production outputs for
manufacturers
Signed new manufacturing and/or distribution agreements in Singapore, the United States, Israel,
South Africa and in January, Australia
Secured five-year at call funding with $30 million At-the-Market facility to accelerate growth
Received $935k R&D tax credit
29 February 2024: Smart building materials company ClearVue Technologies Limited (ASX:CPV; OTC:CVUEF)
(ClearVue or the Company) provides its half year activities report and Appendix 4D for the period ending 31
December 2023 (H1 FY24).
Commenting on the Company’s progress over H1 FY24, CEO Martin Deil said:
“In the first half of FY24 we hit many milestones, accelerating commercialisation in markets around
the world.
“Over the past six months, we’ve had our technology validated by independent, third-party testing,
proven the mass manufacturing capability of our products, and entered into new markets, leading to
our first two commercial contracts in the US and Australia.
1
Suite 7 / 567 Newcastle Street, West Perth, Western Australia 6005
P: +61 8 9220 9020
F: +61 8 9220 9029
E: hello@clearvuepv.com
W: www.clearvuepv.com
“In addition, I’m pleased to report we’ve just had our clear solar glass certified as fire safe and
approved for high rise buildings as well as high-risk environments such as hospitals, schools, and
hotels.
“The fire safe certification is a game changer for the construction industry. Fire performance of
building materials have been under scrutiny globally since the fatal 2017 Grenfell Tower fire in
London. Our products meet rigorous fire testing credentials as well as generate renewable solar
energy that offsets the building’s operational energy requirements, making ClearVue a safe and
sustainable choice for architects, real estate developers, and investors.
“We’ve also delivered our first sales over the half year. Our contract for solar greenhouses targets the
US protected cropping agriculture market and opens an opportunity in global solar greenhouse glass
currently worth US$7.5 billion per year and growing.
“Our contract for a building façade in Australia was significant as this will be the first building to have
our products incorporated into the project design, showing the value that architects are placing on
smart building materials that improve energy efficiency.
“There is increasing pressure on the building and construction sector to achieve sustainability targets.
With first mover advantage, we are ideally placed to service a growing global market for solar
windows and facades, enabled by the strategic distribution and/or manufacturing agreements we’ve
entered into in the US, Australia, Singapore, Israel and South Africa.”
OPERATIONAL OVERVIEW
Commercial orders
In January, ClearVue received its first commercial order in Australia from construction company Kapitol
Group for a new commercial building project for the Construction, Forestry, Maritime, and Employees Union
(CFMEU) in Melbourne. The CFMEU will incorporate Gen-2 ClearVuePV solar windows into the façade of its
new Training and Wellness Centre in Carlton, making it the first project in Australia to specify ClearVue's
unique solar glazing technology from the outset. The ClearVuePV solar glazing is expected to be installed in or
around April 2024.
In October, ClearVue received its first commercial order in the US for supply of ClearVue’s clear solar glass
solutions for greenhouses. Valued at US$158k (A$252k), the order was placed by Greenhouse System USA
Inc. of Watsonville, California. The project will be eligible for incentives created by the US Inflation Reduction
Act and opens a market opportunity in global solar greenhouse glass currently worth US$7.5 billion per year
and growing at 7.2% CAGR.
Product testing and manufacturing capability
Fire safe certification: In February, ClearVue confirmed its clear solar glass has been certified fire safe and
approved for buildings over 18 metres and in high-risk environments such as hospitals, schools, and hotels.
ClearVue’s solar glazing unit met stringent classifications for non-combustibility, little or no smoke
propagation, and no flaming droplets (which contribute to the fire load and fire growth under the condition
of a fully developed fire).
ClearVue’s solar glazing technology generating energy across building envelopes is certified by TÜV SÜD
2
ASX Announcement | 29 February 2024
under the EN 13501-1:2018 standard for fire classification of construction products and building elements.
ClearVue Generation 2 Vision Solar Glass achieved A2-s1, d0 classification rating.
Energy efficiency testing: In October, Singapore’s Building and Construction Authority (BCA) Skylab facility
confirmed ClearVue’s solar glass technology offers significant energy savings when compared against BCA’s
‘Greenmark Platinum’ rated double-glazed low-e product. Testing results demonstrated substantial benefits
for building owners and developers including:
• 22.8% reduction in cooling load and 7.5% overall energy savings after accounting for energy generation
(Gen-2 IGUs only)
• 71% overall energy savings achieved with the addition of ClearVue’s recently announced Spandrel
Solution (Gen-2 IGUs plus the Spandrel Solution)
• Improved thermal comfort for building occupants (PMV index within ASHRAE comfort zone for 96.1% of
time)
• Improvement in imperceptible glare (75.2% of the time v 45.8% for reference cell)
• The integration of Gen-2 PV IGU technology led to lower greenhouse gas emissions and a reduced carbon
footprint for buildings.
Manufacturing capability: In September, ClearVue confirmed its Second-Generation integrated glazing unit
(IGU) design can be produced at mass scale on an unmodified industry-standard production line. The
Company demonstrated continuous production of 80 IGUs with inclusion of the ClearVue PV components
adding only five minutes to the production cycle time compared to normal (non-solar) IGU fabrication – an
over 90% reduction compared against the first generation ClearVue PV IGUs providing cost savings and
increasing production output capability.
Manufacturing and distribution agreements
ClearVue signed new manufacturing and/or distribution agreements with Greendustrial Global in Israel, H T
Glass in Singapore, Concept Business Solutions in South Africa, and 8G Solutions for the US states of Colorado
and Arizona. In January, the Company signed with MS Glass in Australia and a Collaboration Agreement with
vacuum insulated glazing supplier LuxWall in the US to collaborate on the ‘Zero Window’ (see Announcement
of 17 January 2024).
Establishing At-The-Market facility
During the half ClearVue entered a $30 million on-call ‘At-the-Market’ facility (ATM) with Alpha Investment
Partners, providing access to standby equity capital over five years to support the Company’s global growth
plans. ClearVue retains full control over capital raisings and has no obligations to use the facility. In January,
ClearVue used the ATM to raise $1.725 million (before fees) at a 6.7% premium above the 15-day Volume
Weighted Average Price (VWAP).
FINANCIAL UPDATE
At 31 December 2023, the Company had a cash balance of approximately $1.18 million. During the half, the
Company received a tax rebate for its overseas R&D activity of $935k. The company utilised the ATM Facility
raising $1.725 million (before fees) in January 2024 (post balance date).
3
ASX Announcement | 29 February 2024
The Company recorded net operating cash outflows during the half of $4.062 million.
OUTLOOK
Commenting on the Company’s outlook, CEO Martin Deil said:
“We will soon be able to take advantage of the coordinated approach we have taken to enable us to
scale appropriately – namely product innovation, ensuring suitable certification and verification
standards are met, creating seamless at-scale manufacturing capability, setting up our collaborative
manufacturing and distribution agreements to enable us to more effectively scale, and doing pilots
and demonstrations.
“We will start to confirm our sales pipeline and make available our initial product types through our
distributors and manufacturers in key markets.”
Authorised by the Board of ClearVue Technologies Limited.
FOR FURTHER INFORMATION, PLEASE CONTACT:
ClearVue Technologies Ltd
Anna Abrossimova
Head of Marketing
anna@clearvuepv.com
Investors
Media
Adrian Mulcahy
Tristan Everett
adrian.mulcahy@automicgroup.com.au tristan.everett@automicgroup.com.au
+61 (0) 438 630 422
+61 (0) 403 789 096
+61 (0) 401 398 088
ABOUT CLEARVUE TECHNOLOGIES LIMITED
ClearVue Technologies Limited (ASX: CPV) is an Australian technology company that operates in the Building
Integrated Photovoltaic (BPIV) sector which involves integrating solar technology into building surfaces,
specifically glass and building façades, to provide renewable energy. ClearVue has developed advanced glass
technology that preserves glass transparency to maintain building aesthetics whilst generating electricity.
ClearVue’s electricity generating glazing technology is strategically positioned to compliment and make more
compelling the increased use of energy-efficient windows now being regulated in response to global climate
change and energy efficiency goals.
Solar PV cells are incorporated around the edges of an Insulated Glass Unit (IGU) used in windows and the
lamination interlayer between the glass in the IGU incorporates ClearVue’s patented proprietary nano and
micro particles, as well as its spectrally selective coating on the rear external surface of the IGU.
ClearVue’s window technology has application for use in the building and construction and agricultural
industries (among others).
ClearVue has worked closely with leading experts from the Electron Science Research Institute, Edith Cowan
University (ECU) in Perth, Western Australia to develop the technology.
To learn more please visit: www.clearvuepv.com
4
ASX Announcement | 29 February 2024
FORWARD LOOKING STATEMENTS
Statements contained in this release, particularly those regarding possible or assumed future performance,
revenue, costs, dividends, production levels or rates, prices or potential growth of ClearVue Technologies
Limited, are, or may be, forward looking statements. Such statements relate to future events and
expectations and, as such, involve known and unknown risks and uncertainties. Actual results and
developments may differ materially from those expressed or implied by these forward-looking statements
depending on a variety of factors.
5
ASX Announcement | 29 February 2024
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
APPENDIX4D
Consolidated Interim Financial Report for the half-year ended 31 December 2023
1. Name of Entity
ClearVue Technologies Limited (ABN 45 071 397 487)
Reporting Period
Previous Corresponding Reporting Period
2. Results for Announcement to Market
Financial results
Revenue from ordinary activities
Loss after tax from ordinary activities attributable to
members
Loss attributable to members
Half-year ended 31 December 2023
Half-year ended 31 December 2022
Up / Down % Change
100%
Down
Up
Up
Final and interim dividends
Record date for determining entitlements to the dividend
121%
2023
2022
62,210
(7,842,556)
(3,542,548)
121%
(3,542,548)
(7,842,556)
It is not proposed that either a final or interim
dividend be paid.
Not applicable
3. Net Tangible Asset Backing per Ordinary Share
Net tangible asset backing per ordinary share - current reporting period
Net tangible asset backing per ordinary share - previous reporting period
4. Control Gained Over Entities
Details of entities over which control has been gained or lost
5. Dividends Paid and Payable
Details of dividends or distribution payments
6. Dividend Reinvestment Plans
Details of dividend or distribution reinvestment plans
Cents
0.51
4.27
Not applicable
No dividends or distributions are
payable.
Not applicable
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED l;NTITIES
ABN 45 071 397 487
7. Details of Associates
Details of associates and joint venture entities
8. Foreign Entities
Foreign entities to disclose which accounting standards are used in
compiling the report
9. Review Opinion
Details of any audit dispute or qualification
�
Victor Rosenberg
Non-executive Chairman
Perth WA
28 February 2024
Not applicable
Not applicable
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Consolidated Interim Financial Report
For the half-year ended 31 December 2023
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
COMPANY INFORMATION
DIRECTORS
AUDITORS
Victor Rosenberg, Non-executive Chairman
Jamie Lyford, Executive Director
Gerd Hoenicke, Non-executive Director
Charles Mowrey, Non-executive Director
Grant Thornton Audit Pty Ltd
Level 43, Central Park
152-158 St Georges Terrace
Perth WA6000
COMPANY SECRETARY
SOLICITORS
Harry Miller
Brett Tucker
Steinepreis Paganin
16 Milligan Street
Perth WA6000
REGISTERED OFFICE
Suite 9 /567 Newcastle Street
West Perth
WA6005
SHARE REGISTRY
Automic Group
Level2, 267 St Georges Terrace
Perth WA6000
PRINCIPAL BANKERS
National Australia Bank Limited
Level 12, 100 St Georges Terrace
Perth WA6000
STOCK EXCHANGE LISTING
Shares are listed on the Australian Securities
Exchange (ASX code: CPV)
5
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONTENT
PAGE
Directors' Report
1-3
Auditor's Independence Declaration
4
Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income
5
Condensed Consolidated Statement of Financial Position
6
Condensed Consolidated Statement of Changes in Equity
7
Condensed Consolidated Statement of Cash Flows
8
Notes to the Condensed Consolidated Financial Statements
9-19
Directors' Declaration
20
Independent Auditor's Report
21-22
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
DIRECTORS' REPORT
The Directors are pleased to present their Report together with the consolidated financial
statements of ClearVue Technologies Limited ("the Company") and its Controlled Entities ("the
Group") for the half-year ended 31 December 2023.
1.
DIRECTORS
The name of the Directors in office at any time during or since the end of the half-year are:
Victor Rosenberg, Non-executive Chairman
Jamie Lyford, Executive Director
Gerd Hoenicke, Non-executive Director
Charles Mowrey, Non-executive Director
2.
PRINCIPAL ACTIVITIES
The principal activities of the Group during the course of the half-year were research and
development activities applied to the Company's world leading solar glass technology.
3.
REVIEW OF OPERATIONS AND FINANCIAL RESULTS
The operating result of the Group for the current half-year is a loss of $7,842,556 (2022:
$3,542,548).
Operations
During the half-year ended 31 December 2023, the Company focussed on strengthening
its management team (a key appointment being the appointment of CEO Martin Deil),
building out its sales and leads pipeline and sales and execution strategies for the
Company's products in its key geographies of the US and Europe, focussed on licensing
activities to appoint new manufacturers and distributors, completed significant development
work on simplifying the manufacture of its products to ensure fit into the glazing supply
chain, expanded its product mix to cover the entire building envelope, as well as research
and development activities to ensure its innovation and product pipeline is secured for the
future.
Key activities announced or undertaken in the half year include:
•
Demonstrated that second generation ClearVuePV IGUs can be mass produced on an
unmodified industry standard IGU production line through a commercial run with its
Chinese OEM manufacturer. This validation of mass production capabilities is
important for ClearVue's commercialization strategy and ability to partner with glass
manufacturers globally (18 May 2023).
•
Had second generation ClearVuePV IGUs and associated Spandrel Solution
independently tested by the Singapore Building and Construction Authority (BCA)
which confirmed a 22.8% reduction in cooling load and 7.5% overall energy savings
for the IGUs. This third-party verification of product performance benefits is significant
for market adoption and customer confidence (3 October 2023).
•
Secured $30 million, 5-year At-Call Funding Facility with Alpha Investment Partners to
support growth plans and progress towards commercialization. Access to flexible
1
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
DIRECTORS' REPORT
capital is critical to accelerating ClearVue's global expansion plans and progressing
pathways to commercialization (23 October 2023).
•
Appointed leading South African glass company Concept Business Group as exclusive
distributor in South Africa, Botswana and Lesotho, and non-exclusive distributor for
nearby territories. This establishes ClearVue's presence in the African market which is
expected to experience strong construction growth (16 November 2023).
•
Received $935k Research & Development Tax Credit from the Australian Taxation
Office for eligible R&D activities conducted over the past year. Continuous innovation
is important for ClearVue to remain at the cutting edge of BIPV product development
(9 November 2023).
•
Signed agreement with H T Glass Pte Ltd, a leading Singapore glass processing
specialist, for non-exclusive manufacturing and distribution rights in Singapore. This
expands ClearVue's operations into the high growth Southeast Asian market (30
November 2023).
•
Secured first order in the United States for supply of ClearVuePV solar glazing for a
greenhouse project in California with Greenhouse System USA Inc. Greenhouse
markets present a substantial opportunity for ClearVue's technology (30 October
2023).
•
Appointed 8G Solutions as a new non-exclusive distributor in the US states of
Colorado, Missouri and Arizona. 8G Solutions provides an established network to
engage US commercial construction and architecture clients (22 November 2023).
•
Received first commercial order in Australia from construction company Kapitol Group
for ClearVuePV solar windows to be incorporated into the facade of a new Training and
Wellness Centre project in Melbourne for the Construction, Forestry, Maritime, and
Employees Union (CFMEU). This initial reference project builds momentum in
ClearVue's home market (10 January 2024).
•
Signed agreement with leading U.S. vacuum insulated glazing supplier LuxWall Inc. to
develop a combined prototype called the 'Zero Window', aiming to deliver the most
energy efficient and energy generating window. Combining complementary
technologies presents significant market potential (17 January 2024).
•
Secured $1.725 million capital raising through an At-Call Funding Facility with Alpha
Investment Partners, issuing 3 million shares at $0.575 per share. This capital boost
supports ClearVue's accelerated growth progress (15 January 2024).
•
Appointed leading Australian glass manufacturer Safety Glass Pty Ltd trading as MS
Glass as an exclusive manufacturer and distributor in the Australian states of VIC,
NSW, QLD, TAS, ACT for an initial 3 years. MS Glass is well positioned to execute
ClearVue's market entry in key Australian states (8 January 2024).
•
Continued progressing research and development partnerships, product development
and trials including with D2Solar in the US and Murdoch University in Australia.
Continuous innovation is key to product and market leadership.
2
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
DIRECTORS' REPORT
AUDITOR'S INDEPENDENCE DECLARATION
A copy of the Auditor's Independence Declaration as required under section 307C of the
Corporations Act 2001 has been included on page 4.
Signed in accordance with a resolution of the Board of Directors.
Victor Rosenberg
Non-executive Chairman
Perth WA
28 February 2024
3
Grant Thornton Audit Pty Ltd
Level 43 Central Park
152-158 St Georges Terrace
Perth WA 6000
PO Box 7757
Perth WA 6000
T +61 8 9480 2000
Auditor’s Independence Declaration
To the Directors of ClearVue Technologies Limited
In accordance with the requirements of section 307C of the Corporations Act 2001, as lead auditor for the review
of ClearVue Technologies Limited for the half-year ended 31 December 2023, I declare that, to the best of my
knowledge and belief, there have been:
a
no contraventions of the auditor independence requirements of the Corporations Act 2001 in relation to the
review; and
b
no contraventions of any applicable code of professional conduct in relation to the review.
GRANT THORNTON AUDIT PTY LTD
Chartered Accountants
J C Rubelli
Partner – Audit & Assurance
Perth, 28 February 2024
www.grantthornton.com.au
ACN-130 913 594
Grant Thornton Audit Pty Ltd ACN 130 913 594 a subsidiary or related entity of Grant Thornton Australia Limited ABN 41 127 556 389 ACN 127 556 389.
‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or
refers to one or more member firms, as the context requires. Grant Thornton Australia Limited is a member firm of Grant Thornton International Ltd (GTIL).
GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member
firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate one another and are not liable for one
another’s acts or omissions. In the Australian context only, the use of the term ‘Grant Thornton’ may refer to Grant Thornton Australia Limited ABN 41 127
556 389 ACN 127 556 389 and its Australian subsidiaries and related entities. Liability limited by a scheme approved under Professional Standards
Legislation.
4
w
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONDENSED CONSOLIDATED STATEMENT OF PROFIT AND LOSS AND OTHER
COMPREHENSIVE INCOME
AS AT 31 DECEMBER 2023
Consolidated
31 Dec 2023
$
Revenue from contracts with customers
Other income
Consulting expense
Depreciation and amortisation expense
Employee benefits expense
Finance costs
Legal fees
Material costs
Project costs
Share-based payments
Travel expense
Other expenses
5
6
Loss before income tax
Consolidated
31 Dec 2022
$
593,985
593,985
62,210
532,286
594,496
{1,965,612)
(268,697)
(1,072,994)
{4,494)
(146,401)
(437,428)
(1,230,258)
(137,050)
(715,865)
(7,379)
(39,460)
(266,075)
(3,513,764)
(407,291)
(619,860)
(8,436,541)
(889,505)
(203,227)
(648,225)
(4,137,044)
(7,842,556)
(3,542,548)
(7,842,556)
{3,542,548)
(7,842,556)
(3,542,548)
(3.59)
(3.59)
(1.66)
(1.66)
Income tax expense
Loss for the period
Other comprehensive income/loss
Total comprehensive loss for the period
Loss per share for loss attributable to the
owners of the Company (cents)
Basic loss per share
Diluted loss per share
12
12
See accompanying notes to the financial statements
5
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023
Consolidated
31 Dec 2023
$
Consolidated
30 Jun 2023
$
1,177,571
623,189
263,308
2,064,068
5,164,663
1,008,835
382,304
6,555,802
501,851
118,956
5,607,726
75,684
6,304,217
316,804
158,984
5,115,101
56,682
5,647,571
8,368,285
12,203,373
1,170,661
91,207
135,477
1,397,345
1,170,876
126,757
107,203
1,404,836
18,655
58,382
77,037
30,724
45,492
76,216
Total Liabilities
1,474,382
1,107,745
Net Assets
6,893,903
10,722,321
32,945,212
8,593,328
(34,644,637)
32,360,091
6,039,351
(27,677,121)
6,893,903
10,722,321
Note
ASSETS
Current Assets
Cash and cash equivalents
Trade and other receivables
Other assets
Total Current Assets
7
Non-Current Assets
Plant and equipment
Right-of-use asset
Intangible assets
Other assets
Total Non-Current Assets
8
Total Assets
LIABILITIES
Current Liabilities
Trade and other payables
Lease liabilities
Provisions
Total Current Liabilities
9
Non-Current Liabilities
Lease liabilities
Provisions
Total Non-Current Liabilities
9
EQUITY
Share capital
Share-based payments reserve
Accumulated losses
10
11
Total Equity
See accompanying notes to the financial statements
6
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE HALF-YEAR ENDED 31 DECEMBER 2023
Share
Capital
$
Balance at 1 July 2022
31,373,822
Share-Based
Payments
Reserve
$
Accumulated
Losses
$
Total
$
5,742,782
(20,660,029)
16,456,575
(3,542,548)
(3,542,548)
(3,542,548)
(3,542,548)
Loss after income tax expense
Other comprehensive income
Total comprehensive loss for the
period
Options exercised
Share based payments
Options vested
Performance shares lapsed
200,000
767,500
122,005
(480,000)
480,000
200,000
767,500
122,005
Balance at 31 December 2022
32,341,322
5,384,787
(23,722,577)
14,003,532
Balance at 1 July 2023
32,360,091
6,039,351
(27,677,121)
10,722,321
(7,842,556)
(7,842,556)
(7,842,556)
(7,842,556)
Loss after income tax expense
Other comprehensive income
Total comprehensive loss for the
period
Options exercised
Options exercised - Shares
Issued
Shares based payments Shares issued
Options vested
Performance rights issued
Options issued ESOP
Options lapsed
Director loan repaid
Balance at 31 December 2023
(492,366)
492,366
481,625
481,625
103,496
103,496
32,945,212
49,976
1,569,865
1,790,427
(342,952)
(20,973)
342,952
39,722
8,593,328
(34,644,637)
See accompanying notes to the financial statements
7
49,976
1,569,865
1,790,427
18,749
6,893,903
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE HALF-YEAR ENDED 31 DECEMBER 2023
Consolidated
31 Dec 2023
$
Consolidated
31 Dec 2022
$
(7,842,556)
(3,542,548)
Exchange gain on foreign bank accounts
Depreciation of plant and equipment
Amortisation of intangible assets
Share-based payments
Operating loss before working capital changes
(2,866)
110,314
158,382
3,513,764
(4,062,962)
(61,485)
69,324
67,726
889,505
(2,577,478)
Changes in working capital:
Decrease in trade and other receivables
Decrease in other assets
(Decrease) in trade and other payables
Increase in provisions
Net cash (used in) operating activities
385,646
99,994
(215)
41,164
(3,536,373)
511,298
39,527
(92,449)
5,793
(2,113,309)
Cash flows from investing activities
Patents and trademarks expenditure
Research and development expenditure
Purchase of plant & equipment
Net cash (used in) investing activities
(458,711)
(223,130)
(192,288)
(874,129)
(234,862)
(245,511)
(9,977)
(490,351)
Cash flows from financing activities
Former Director loan repaid
Options exercised
Lease payments
Net cash from financing activities
18,750
481,626
(79,832)
420,544
200,000
(56,527)
143,474
Net (decrease) in bank balances
Effect of currency translation on cash
Bank balances at beginning of half-year
(3,989,958)
2,866
5,164,663
(2,460,186)
61,485
11,753,873
Bank balances at end of half-year
1,177,571
9,355,172
Cash flows from operating activities
Loss before income tax
Adjustment for:
See accompanying notes to the financial statements
8
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE HALF-YEAR ENDED 31 DECEMBER 2023
These notes form an integral part of and should be read in conjunction with the accompanying financial
report:
1.
GENERAL INFORMATION
Nature of Operations
The principal activities of the Group include research and development activities related to the
Company's world leading solar glass technology and commercialisation activities for the same.
Basis of Preparation and Statement of Compliance
This general purpose consolidated interim financial statements have been prepared in accordance
with the requirements of the Corporations Act 2001 and AASB 134 'Interim Financial Reporting'.
They do not include all of the information required in annual financial statements in accordance with
Australian Accounting Standards, and should be read in conjunction with the Annual Report of the
Group for the year ended 30 June 2023 and any public announcements made by the Group during
the half-year in accordance with continuous disclosure requirements arising under the Australian
Securities Exchange Listing Rules and Corporations Act 2001.
New Standards adopted at 1 July 2023
There are no accounting pronouncements which have become e
Share your feedback
Discover